ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05144	Malaria	1/1	45/7206	0.00624479600336
ko05321	Inflammatory bowel disease (IBD)	1/1	56/7206	0.00777130169305
ko05134	Legionellosis	1/1	74/7206	0.0102692200944
ko05140	Leishmaniasis	1/1	75/7206	0.0104079933389
ko05130	Pathogenic Escherichia coli infection	1/1	77/7206	0.0106855398279
ko05133	Pertussis	1/1	87/7206	0.0120732722731
ko05323	Rheumatoid arthritis	1/1	89/7206	0.0123508187622
ko04064	NF-kappa B signaling pathway	1/1	96/7206	0.0133222314738
ko05132	Salmonella infection	1/1	98/7206	0.0135997779629
ko05146	Amoebiasis	1/1	99/7206	0.0137385512073
ko04620	Toll-like receptor signaling pathway	1/1	100/7206	0.0138773244518
ko05162	Measles	1/1	120/7206	0.0166527893423
ko04066	HIF-1 signaling pathway	1/1	123/7206	0.0170691090759
ko05145	Toxoplasmosis	1/1	126/7206	0.0174854288093
ko05142	Chagas disease (American trypanosomiasis)	1/1	130/7206	0.0180405217875
ko04621	NOD-like receptor signaling pathway	1/1	157/7206	0.0217873993895
ko04145	Phagosome	1/1	162/7206	0.022481265612
ko05164	Influenza A	1/1	167/7206	0.0231751318347
ko05161	Hepatitis B	1/1	173/7206	0.0240077713018
ko04217	Necroptosis	1/1	178/7206	0.0247016375244
ko05152	Tuberculosis	1/1	187/7206	0.0259505967251
ko05205	Proteoglycans in cancer	1/1	271/7206	0.0376075492647